Spinal Muscle Atrophy (SMA) is a nasty genetic disease. However, advances in medical research has brought a drug to the market with a high cost. Without a doubt the debate will rage as to whether the cost of treatment is worth the life it is saving. To add a little bit of perspective, about 1 in 10,000 babies are born with spinal muscular atrophy. This equates to about 400 a year in the United States.  SMA … [Read more...]